AMSTERDAM, June 14 /PRNewswire/ -- Primagen Holding BV, an emerging company in molecular diagnostics for infectious diseases and cancer, today announced that its special dry filter paper (DFS) technology has been internally validated for use with the Roche COBAS AMPLICOR® HIV-1 test v 1.5. DFS will give HIV/AIDS care providers a simple, cost effective sample collection system for patients requiring monitoring of their HIV-1 viral load using tests including the Roche COBAS AMPLICOR® HIV-1 test v 1.5. Full results of the study will be presented at the 14th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), June 21-23, in Toulon, France.
